Company Filing History:
Years Active: 1999-2003
Title: The Innovations of David L. Cutler
Introduction
David L. Cutler is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of viral infections. With a total of 7 patents to his name, Cutler's work has had a profound impact on the medical community.
Latest Patents
Among his latest patents is the "Polyethylene glycol modified interferon therapy." This method involves administering a PEG-IFN alpha conjugate to individuals afflicted with viral infections, particularly chronic hepatitis C. Another significant patent is the "Continuous low-dose cytokine infusion therapy." This method aims to treat conditions susceptible to cytokine treatment while minimizing undesirable side effects. It involves the continuous administration of a low dose of a cytokine, with a preferred embodiment focusing on chronic hepatitis C treatment through low-dose interferon.
Career Highlights
David L. Cutler has had a distinguished career, working with Schering Corporation, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in therapeutic methods that improve patient outcomes.
Collaborations
Throughout his career, Cutler has collaborated with notable colleagues, including Melton B. Affrime and Paul William Glue. These collaborations have further enhanced the development and implementation of his innovative therapies.
Conclusion
David L. Cutler's contributions to medical innovation, particularly in the treatment of chronic hepatitis C, highlight his role as a leading inventor in the field. His patents reflect a commitment to improving therapeutic methods and patient care.